Heart Failure
Clinical Indications and Science Learning Series
Guidelines, Decision Making & Controversies
Episodes
A Treatment Algorithm for GDMT in FMR Patients (Including ‘Dynamic’ MR)
13 min.
Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?
4 min.
Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 1
7 min.
Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 2
7 min.
Regulatory Considerations for the Use of AI for Treating Patients With Heart Failure: The Intersection of Drugs and Devices
11 min.
This Strategy Has Saved the Startup Medical Device Sector
7 min.
Down-Stream Challenges: Reimbursement and Guidelines
8 min.
Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies
10 min.
Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies
12 min.
Which ADHF Patients Need Devices?: A Clinician's Perspective
9 min.
Current Challenges Related to Device-Based Therapies for ADHF: Perspectives of an Investigator
7 min.
Current Challenges Related to Device-Based Therapies for ADHF: Perspectives from Industry
8 min.
What Are the Major Challenges?
9 min.
Clinical Trial Options
8 min.
How Helpful Can EFIC Be in the US?
29 min.
Inflammation and HFpEF: Rationale for HERMES
9 min.
Inflammation as a Target in Acute HF
10 min.
Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?
10 min.
Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence
9 min.
How Does Weight Loss Improve Hemodynamics in Patients With HFpEF
10 min.
From Obesity to Inflammation: Common Pathways and New Opportunities in HF
10 min.
Resurgence of Interest in the Role of Inflammaion in HF
10 min.
Obesity: Assessing the Weight of the Evidence
9 min.
MRAs Redux: New Evidence in Heart Failure
12 min.
Special Late-Breaking Clinical Science Abstract: Electrophysiological Characteristics and Clinical Outcomes of Truncal, Fascicular and Left Ventricular Septal Pacing in Patients Receiving Left Bundle Branch Area Pacing
11 min.
Is There a Difference in the Benefits of AF Ablation in HFrEF vs HFpEF?
13 min.
Left Bundle Branch Area Pacing: Implications for Long Term LV Function in Heart Failure
12 min.
Advances in Defibrillation for Patients With Heart Failure: Extravascular ICD and Beyond
13 min.
Left Atrial Appendage Closure: Should We Give Heart Failure Patients With AF the OPTION
14 min.
Shaping the Future of Heart Failure
10 min.
Mineralocorticoid Antagonism in Heart Failure: Mechanistic Foundations
10 min.
Too Good to Be True? Five Top Lessons of Major GLP-1 Agonists Trials
18 min.
Growing Role of AI in HF Diagnostics: Are There Any Pitfalls
10 min.
Patient Reported Outcomes in National Registries: Why and How?
22 min.
Case Resolution: TTVI in the Failing Right Heart
9 min.
TTVI in in the Failing Right Heart
16 min.
Case Presentation: TTVI in the Failing Right Heart
3 min.
Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients
18 min.
The Concepts of Biological and Physical Reverse Remodeling
15 min.